Clinical Trials
4 trialsNCT06869239 2025-03-11
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Peking University Cancer Hospital & Institute
Recruiting
NCT06780826 2025-01-17
A Study on the Efficacy of Atezolizumab Combined with Chemotherapy
Shanghai Pulmonary Hospital, Shanghai, China
Recruiting
NCT04679506 2020-12-22
the Efficacy and Safety of CLAE in R/R T-ALL/LBL
Peking University Third Hospital
Unknown
NCT03130582 2017-04-28
High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Completed